High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response

被引：0
|
作者：
Hui Gao
Joshua M Korn
Stéphane Ferretti
John E Monahan
Youzhen Wang
Mallika Singh
Chao Zhang
Christian Schnell
Guizhi Yang
Yun Zhang
O Alejandro Balbin
Stéphanie Barbe
Hongbo Cai
Fergal Casey
Susmita Chatterjee
Derek Y Chiang
Shannon Chuai
Shawn M Cogan
Scott D Collins
Ernesta Dammassa
Nicolas Ebel
Millicent Embry
John Green
Audrey Kauffmann
Colleen Kowal
Rebecca J Leary
Joseph Lehar
Ying Liang
Alice Loo
Edward Lorenzana
E Robert McDonald
Margaret E McLaughlin
Jason Merkin
Ronald Meyer
Tara L Naylor
Montesa Patawaran
Anupama Reddy
Claudia Röelli
David A Ruddy
Fernando Salangsang
Francesca Santacroce
Angad P Singh
Yan Tang
Walter Tinetto
Sonja Tobler
Roberto Velazquez
Kavitha Venkatesan
Fabian Von Arx
Hui Qin Wang
Zongyao Wang
机构：
[1] Oncology Disease Area,Department of Oncology Translational Medicine
[2] Novartis Institutes for Biomedical Research,undefined
[3] Oncology Disease Area,undefined
[4] Novartis Institutes for Biomedical Research,undefined
[5] Novartis Institutes for Biomedical Research,undefined
[6] China Novartis Institutes for Biomedical Research,undefined
[7] Oncology Disease Area,undefined
[8] Novartis Institutes for Biomedical Research,undefined
[9] Present addresses: Patronus Therapeutics,undefined
[10] Inc.,undefined
[11] San Francisco,undefined
[12] California,undefined
[13] USA (M.S.); Janssen China R&D and Scientific Affairs,undefined
[14] Shanghai,undefined
[15] China (C.Z.); BioMarin Pharmaceutical,undefined
[16] Inc.,undefined
[17] Novato,undefined
[18] California,undefined
[19] USA (N.K.P.); and Duke University,undefined
[20] Durham,undefined
[21] North Carolina,undefined
[22] USA (A.R.).,undefined
来源：
Nature Medicine | 2015年 / 21卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The authors implement a collection of patient-derived xenograft tumors to test cancer drug responses.
引用
收藏
页码：1318 / 1325
页数：7
相关论文
共 50 条
  • [31] A HIGH-THROUGHPUT IN VITRO DRUG SCREEN OF PATIENT-DERIVED GLIOMATOSIS CEREBRI CELLS FOR PRECISION MEDICINE
    Maachani, Uday Bhanu
    Rajappa, Prajwal
    Voronina, Julia C.
    Souweidane, Mark M.
    Greenfield, Jeffrey P.
    NEURO-ONCOLOGY, 2017, 19 : 23 - 23
  • [32] Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response
    Zhang, Feifei
    Wang, Wenjie
    Long, Yuan
    Liu, Hui
    Cheng, Jijun
    Guo, Lin
    Li, Rongyu
    Meng, Chao
    Yu, Shan
    Zhao, Qingchuan
    Lu, Shun
    Wang, Lili
    Wang, Haitao
    Wen, Danyi
    CANCER COMMUNICATIONS, 2018, 38 : 1 - 12
  • [33] Acoustic Droplet-Assisted Superhydrophilic-Superhydrophobic Microarray Platform for High-Throughput Screening of Patient-Derived Tumor Spheroids
    Xia, Yu
    Chen, Hui
    Li, Juan
    Hu, Hang
    Qian, Qun
    He, Rong-Xiang
    Ding, Zhao
    Guo, Shi-Shang
    ACS APPLIED MATERIALS & INTERFACES, 2021, 13 (20) : 23489 - 23501
  • [34] High-throughput bioprinting of the nasal epithelium using patient-derived nasal epithelial cells
    Derman, I. Deniz
    Yeo, Miji
    Castaneda, Diana Cadena
    Callender, Megan
    Horvath, Mian
    Mo, Zengshuo
    Xiong, Ruoyun
    Fleming, Elizabeth
    Chen, Phylip
    Peeples, Mark E.
    Palucka, Karolina
    Oh, Julia
    Ozbolat, Ibrahim T.
    BIOFABRICATION, 2023, 15 (04)
  • [35] Protocol for drug screening of patient-derived tumor organoids using high-content fluorescent imaging
    Larsen, Brian M.
    Cancino, Andrea
    Shaxted, Jenna M.
    Salahudeen, Ameen A.
    STAR PROTOCOLS, 2022, 3 (02):
  • [36] Development and validation of a high-throughput drug screen (HTDS) from patient-derived tumor organoids (PDTO) from gastrointestinal malignancies: Clinical and genomic correlations
    Khan, U.
    Singh, S.
    Us, I.
    Sarkar, S.
    Alban, T.
    Chan, T.
    Hissong, E.
    Bhinder, B.
    Moyer, J.
    Martin, L.
    Shah, M. A.
    ANNALS OF ONCOLOGY, 2024, 35 : S210 - S210
  • [37] Combination of molecular and drug response data in patient-derived xenografts to assist patient stratification
    Cairo, S.
    Deas, O.
    Beurdeley, A.
    Yvonnet, V.
    Poupon, M. F.
    Judde, J. G.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 58 - 58
  • [38] Assessment of functional signal transduction pathway activity in patient-derived tumor xenografts to predict and evaluate therapy response
    Verhaegh, W.
    van de Stolpe, A.
    Holtzer, L.
    De Regt, B.
    Wrobel, J.
    Posch, M.
    Caushaj, N.
    Maier, A.
    Metz, T.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E84 - E85
  • [39] Patient-Derived Melanoma Immune-Tumoroids as a Platform for Precise High throughput Drug Screening
    Viegas, Juliana
    Costa, Sofia
    Dias, Sofia
    Pereira, Catarina Leite
    Sarmento, Bruno
    ADVANCED SCIENCE, 2024, 11 (48)
  • [40] Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicine
    Langenberg, Karin P. S.
    van Hooff, Sander R.
    Koopmans, Bianca
    Strijker, Josephine G. M.
    Kholosy, Waleed M.
    Ober, Kimberley
    Zwijnenburg, Danny A.
    van der Hoek, Jessica J. F.
    Keller, Kaylee M.
    Vernooij, Lindy
    Schild, Linda G.
    Looze, Eleonora J.
    Ebus, Marli E.
    Essing, Anke H. W.
    de Vree, Paula
    Tas, Michelle L.
    Matser, Yvette A. H.
    Wienke, Judith
    Volckmann, Richard
    Tops, Bastiaan B. J.
    Kester, Lennart A.
    Badloe, Shashi
    Hehir-Kwa, Jayne Y.
    Kemmeren, Patrick
    Goemans, Bianca F.
    Zwaan, C. Michel
    Oehme, Ina
    Jager, Nathalie
    Witt, Olaf
    van Eijkelenburg, Natasha K. A.
    Dierselhuis, Miranda P.
    Tytgat, Godelieve A. M.
    Wijnen, Marc H. W.
    van Noesel, Max M.
    de Krijger, Ronald R.
    Eising, Selma
    Koster, Jan
    Dolman, Emmy M.
    Molenaar, Jan J.
    EUROPEAN JOURNAL OF CANCER, 2025, 218
12345